Methadone and torsade de pointes: How can we better understand the association?

American Journal of Medicine

Volumn 126, Issue 9, 2013, Pages 757-758

  Hasnain, Mehrul ^a   Vieweg, W Victor R ^b   Breden Crouse, Ericka L ^c   Hancox, Jules C ^d  

^a MEMORIAL UNIVERSITY OF NEWFOUNDLAND   (Canada)

^b VIRGINIA COMMONWEALTH UNIVERSITY SCHOOL OF MEDICINE   (United States)

^c VIRGINIA COMMONWEALTH UNIVERSITY   (United States)

^d UNIVERSITY OF BRISTOL   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

COCAINE; METHADONE; POTASSIUM;

DISEASE ASSOCIATION; DISEASE MARKER; DOSE RESPONSE; DRUG BLOOD LEVEL; DRUG USE; ELECTROCARDIOGRAPHY MONITORING; HEART DISEASE; HEART REPOLARIZATION; HUMAN; HYPOKALEMIA; HYPOMAGNESEMIA; LIVER DYSFUNCTION; METHADONE TREATMENT; NOTE; OPIATE ADDICTION; PATIENT MONITORING; POTASSIUM BLOOD LEVEL; PRIORITY JOURNAL; QT INTERVAL; QT PROLONGATION; RISK FACTOR; SINUS BRADYCARDIA; TORSADE DES POINTES;

EID: 84883250661     PISSN: 00029343     EISSN: 15557162     Source Type: Journal    
DOI: 10.1016/j.amjmed.2013.03.013     Document Type: Editorial

References (8)

1. S. Mayet, M. Gossop, N. Lintzeris, V. Markides, and J. Strang Methadone maintenance, QTc and torsade de pointes: who needs an electrocardiogram and what is the prevalence of QTc prolongation? Drug Alcohol Rev 30 4 2011 388 396
2. A.N. Katchman, K.A. McGroary, and M.J. Kilborn Influence of opioid agonists on cardiac human ether-a-go-go-related gene K(+) currents J Pharmacol Exp Ther 303 2 2002 688 694
3. J.C. Hancox, M.J. McPate, H.A. El, and Y.H. Zhang The hERG potassium channel and hERG screening for drug-induced torsades de pointes Pharmacol Ther 119 2 2008 118 132
4. Vieweg VRW, Hasnain M, Howland RH, et al. Methadone, QTc interval prolongation and torsade de pointes: case reports offer the best understanding of this problem. Ther Adv Psychopharmacol. In press. doi 10.1177/ 2045125312469982.
5. M.M. Bednar, E.P. Harrigan, R.J. Anziano, A.J. Camm, and J.N. Ruskin The QT interval Prog Cardiovasc Dis 43 5 Suppl 1 2001 1 45
6. M.J. Krantz, I.B. Kutinsky, A.D. Robertson, and P.S. Mehler Dose-related effects of methadone on QT prolongation in a series of patients with torsade de pointes Pharmacotherapy 23 6 2003 802 805
7. M. Stallvik, B. Nordstrand, O. Kristensen, J. Bathen, E. Skogvoll, and O. Spigset Corrected QT interval during treatment with methadone and buprenorphine - Relation to doses and serum concentrations Drug Alcohol Depend 129 1-2 2013 88 93
8. Hasnain M. Report cases of drug-induced QTc prolongation with or without TdP. Available at: http://www.qtcprolongation.com. Accessed January 10, 2013.